Understanding malignant mesothelioma and the way it develops is significant when discovering prevention, development control, and the eventual lead to a cure. Cancer researchers at the Mayo Clinic have been researching the genetic composition of the disease in hopes to find a connection between the development of mesothelioma and mutations[…]
Novel Treatments & Drugs
New mesothelioma treatment method may prolong the effectiveness of chemotherapy combination
Chemotherapy remains one of the most effective treatments for mesothelioma. Because there is no cure, it works to prolong the lives of patients. Unfortunately, even the most effective methods can become inadequate as treatments continue. A current clinical trial is attempting to extend the usefulness period of chemotherapy and in[…]
Adding an inhibitor to mesothelioma treatment proves effective
A recent mesothelioma study found the addition of bevacizumab to the chemotherapy treatment of pemetrexed plus cisplatin may increase the survival rate in patients. From 2008 to 2014, patients were given the standard treatment in 21-day increments for six cycles, with some receiving bevacizumab. The addition of bevacizumab increased survival[…]
Study finds new treatment boosts chemotherapy results in mesothelioma
Researchers with the National Cancer Institute recently found an immunotoxin may increase the efficacy of chemotherapy. When combined with popular treatments cisplatin and pemetrexed, SS1P caused antitumor activity in patients. SS1P is an immunotoxin, a protein made by humans with a large targeting section linked to a toxin. Specifically, SS1P[…]
Grapes and leukemia treatment may help mesothelioma
Several research articles recently published detail new and innovative drug solutions to fight mesothelioma. Scientists from around the world continue to develop potential solutions with Korea releasing their findings tied to a leukemia treatment and red wine. Published in Biochemistry and Molecular Biology, the study found clofarabine, a drug typically[…]
New mesothelioma detection method exposes subjects to less radiation
To monitor a patient for mesothelioma involves subjecting them to CT scans with high levels of radiation. Repeated screenings increase risks for other health issues. For workers exposed to asbestos, these scans are necessary for survival even with the drawbacks. A study out of France found a new CT method[…]
Mesothelioma treatments found in unlikely places
Scientists around the world work endlessly to discover new treatments for mesothelioma. Taking decades to develop, the asbestos-caused cancer leaves most with less than a year to live after diagnosis. Many studies focus on the effectiveness of current treatments, hoping to expand current knowledge and provide victims with the best[…]
New study suggests breast cancer drug may shrink mesothelioma tumors
After new evidence surfaced suggesting the enzyme aromatase is associated with malignant mesothelioma, Italian scientists began testing breast cancer drug Aromasin (exemestane) on mice and mesothelioma cells. Designed to inhibit aromatase, Aromasin curbs cell growth in breast cancer patients by helping reduce the amount of estrogen in the body. In[…]
Alimta remains best treatment for victims of malignant pleural mesothelioma
For those with inoperable malignant pleural mesothelioma, Alimta (permetrexed) combined with cisplatin remains the top treatment. Japanese researchers recently analyzed the results of 30 patients taking either Gemzar or the Alimta combination and compared complications, disease control and survival rates. Thirty mesothelioma cases were examined featuring 13 patients taking Gemzar[…]
